logo

Millendo Therapeutics, Inc (MLND)



Trade MLND now with
  Date
  Headline
11/9/2020 8:42:11 AM Millendo Therapeutics Q3 Net Loss $6.4 Mln Or $0.34/Shr Vs Loss $11.6 Mln Or $0.87/Shr Last Year
8/10/2020 8:34:34 AM Millendo Therapeutics Q2 Net Loss $10.7 Mln Vs Loss $9.9 Mln Last Year
5/8/2020 8:49:25 AM Millendo Therapeutics Q1 Loss/Shr $0.65 Vs Loss $0.78 Last Year
4/6/2020 7:06:36 AM Millendo Therapeutics Says It Is Discontinuing Development Of Livoletide For Prader-Willi Syndrome
3/11/2020 8:35:03 AM Millendo Therapeutics FY Net Loss $44.6 Mln Vs Loss $27.2 Mln Last Year
1/9/2020 8:34:43 AM Millendo Therapeutics Promotes Thomas Hoover To Chief Commercial Officer
12/19/2019 8:33:05 AM Millendo Therapeutics Adds Geoff Nichol To Board